Gregory Philip A, Bert Andrew G, Paterson Emily L, Barry Simon C, Tsykin Anna, Farshid Gelareh, Vadas Mathew A, Khew-Goodall Yeesim, Goodall Gregory J
Hanson Institute and Division of Human Immunology, Institute of Medical and Veterinary Science, Adelaide, SA 5000, Australia.
Nat Cell Biol. 2008 May;10(5):593-601. doi: 10.1038/ncb1722. Epub 2008 Mar 30.
Epithelial to mesenchymal transition (EMT) facilitates tissue remodelling during embryonic development and is viewed as an essential early step in tumour metastasis. We found that all five members of the microRNA-200 family (miR-200a, miR-200b, miR-200c, miR-141 and miR-429) and miR-205 were markedly downregulated in cells that had undergone EMT in response to transforming growth factor (TGF)-beta or to ectopic expression of the protein tyrosine phosphatase Pez. Enforced expression of the miR-200 family alone was sufficient to prevent TGF-beta-induced EMT. Together, these microRNAs cooperatively regulate expression of the E-cadherin transcriptional repressors ZEB1 (also known as deltaEF1) and SIP1 (also known as ZEB2), factors previously implicated in EMT and tumour metastasis. Inhibition of the microRNAs was sufficient to induce EMT in a process requiring upregulation of ZEB1 and/or SIP1. Conversely, ectopic expression of these microRNAs in mesenchymal cells initiated mesenchymal to epithelial transition (MET). Consistent with their role in regulating EMT, expression of these microRNAs was found to be lost in invasive breast cancer cell lines with mesenchymal phenotype. Expression of the miR-200 family was also lost in regions of metaplastic breast cancer specimens lacking E-cadherin. These data suggest that downregulation of the microRNAs may be an important step in tumour progression.
上皮-间质转化(EMT)在胚胎发育过程中促进组织重塑,被视为肿瘤转移的关键早期步骤。我们发现,微小RNA-200家族的所有五个成员(miR-200a、miR-200b、miR-200c、miR-141和miR-429)以及miR-205在因转化生长因子(TGF)-β或蛋白酪氨酸磷酸酶Pez的异位表达而发生EMT的细胞中显著下调。单独强制表达miR-200家族足以阻止TGF-β诱导的EMT。这些微小RNA共同协同调节E-钙黏蛋白转录抑制因子ZEB1(也称为δEF1)和SIP1(也称为ZEB2)的表达,这些因子先前与EMT和肿瘤转移有关。抑制这些微小RNA足以在需要上调ZEB1和/或SIP1的过程中诱导EMT。相反,在间充质细胞中异位表达这些微小RNA会引发间充质-上皮转化(MET)。与其在调节EMT中的作用一致,在具有间充质表型的侵袭性乳腺癌细胞系中发现这些微小RNA的表达缺失。在缺乏E-钙黏蛋白的化生型乳腺癌标本区域中,miR-200家族的表达也缺失。这些数据表明,微小RNA的下调可能是肿瘤进展中的一个重要步骤。